Universe Pharmaceuticals INC (UPC) reporting calendar
Universe Pharmaceuticals INC files periodic reports with the SEC as UPC on Nasdaq. Atlas tracks 5 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 30 Sep 2025
- Filed
- 29 Jan 2026
- Reports on record
- 5
Open UPC market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 30 Sep 2025 | 29 Jan 2026 | 121 days | 0001213900-26-009000 |
| 20-F | 30 Sep 2024 | 29 Apr 2025 | 211 days | 0001213900-25-036798 |
| 20-F | 30 Sep 2023 | 30 Jan 2024 | 122 days | 0001213900-24-007745 |
| 20-F | 30 Sep 2022 | 10 Feb 2023 | 133 days | 0001213900-23-010349 |
| 20-F | 30 Sep 2021 | 31 Jan 2022 | 123 days | 0001213900-22-004359 |
Source: SEC EDGAR company submissions for CIK 0001809616. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.